Deal in Place for Inspecting Foreign Drugs

Saturday, August 13, 2011 - 00:10 in Mathematics & Economics

The companies would pay $299 million a year to underwrite government inspections of manufacturing plants abroad, reducing the risk of tainted drugs and speeding approval of their products.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net